publication date: Jul. 11, 2014

html Briefs.html

In Brief
Three Named to Leadership Posts at St. Jude; Mitchell Weiss Appointed Chair of Hematology

announced the appointment of three physician-scientists to leadership positions.

Mitchell Weiss was named chair of the St. Jude Department of Hematology. He was recruited to the institution from the University of Pennsylvania Perelman School of Medicine and the Children’s Hospital of Philadelphia, where he was professor of pediatrics and held an endowed chair.

J. Paul Taylor, who joined the St. Jude Department of Developmental Neurobiology in 2008, was appointed chair of the new St. Jude Department of Cell and Molecular Biology. He will also hold the Edward F. Barry Endowed Chair in Cell and Molecular Biology.

Kim Nichols was selected to launch the new Division of Hereditary Cancer Predisposition in the St. Jude Department of Oncology. She currently directs the CHOP Pediatric Hereditary Cancer Predisposition Program. She is also an associate professor of pediatrics at the UPenn Perelman School of Medicine.

joined the University of Florida College of Medicine’s department of health outcomes and policy and will serve as director of biomedical informatics at UF’s Clinical and Translational Science Institute.

Hogan will lead the development of a medical informatics training program and support services for researchers who need assistance with managing and analyzing large medical data sets.

He previously served as the chief of the University of Arkansas for Medical Sciences’ division of biomedical informatics.

joined the Medical University … Continue reading 40-28 In Brief: Three Named to Leadership Posts at St. Jude; Weiss Appointed Chair of Hematology

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.